Food and Drug Administration/Xavier University PharmaLink Conference-Leadership in a Global Supply Chain, 9229 [2014-03454]
Download as PDFAgencies
[Federal Register Volume 79, Number 32 (Tuesday, February 18, 2014)] [Notices] [Page 9229] From the Federal Register Online via the Government Printing Office [www.gpo.gov] [FR Doc No: 2014-03454] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2014-N-0001] Food and Drug Administration/Xavier University PharmaLink Conference--Leadership in a Global Supply Chain AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public conference. ----------------------------------------------------------------------- The Food and Drug Administration (FDA) Cincinnati District, in cosponsorship with Xavier University, is announcing a public conference entitled ``FDA/Xavier University PharmaLink Conference: Leadership in a Global Supply Chain.'' The public conference seeks solutions to important and complicated issues by aligning with the strategic priorities of FDA, and includes presentations from key FDA officials, global regulators, and industry experts. Each presentation challenges the status quo and conventional wisdom to create synergies focused on finding solutions which make a difference. The experience level of the audience has fostered engaged dialog that has led to innovative initiatives. Dates and Times: The public conference will be held on March 19 and 20, 2014, from 8:30 a.m. to 5 p.m. and March 21, 2014, from 8:30 a.m. to 12:15 p.m. Location: The public conference will be held on the campus of Xavier University, 3800 Victory Pkwy., Cincinnati, OH 45207, 513-745- 3073 or 513-745-3020. Contact Persons: For information regarding this notice: Steven Eastham, Food and Drug Administration, Cincinnati South Office, 36 East 7th Street, Cincinnati, OH, 45202, 513-246-4134, email: steven.eastham@fda.hhs.gov. For information regarding the conference and registration: Marla Phillips, Xavier University, 3800 Victory Pkwy., Cincinnati, OH 45207, 513-745-3073, email: phillipsm4@xavier.edu. Registration: There is a registration fee. The conference registration fees cover the cost of the presentations, training materials, receptions, breakfasts, lunches, and dinners for the 2 1/2 days of the conference. There will be onsite registration. The cost of registration is as follows: Table1.--Registration Fees \1\ ------------------------------------------------------------------------ Registration Attendee type fees ------------------------------------------------------------------------ Industry................................................ $1,895 Small Business (<100 employees)......................... $1,295 Startup Manufacturer.................................... $300 Academic................................................ $300 Media................................................... Free Government.............................................. Free ------------------------------------------------------------------------ \1\ The fourth registration from the same company is free--all four attendees must register at the same time. The following forms of payment will be accepted: American Express, Visa, Mastercard, and company checks. To register online for the public conference, please visit the ``Registration'' link on the conference Web site at https://www.XavierPharmaLink.com. FDA has verified the Web site address, but is not responsible for subsequent changes to the Web site after this document publishes in the Federal Register. To register by mail, please send your name, title, firm name, address, telephone and fax numbers, email, and payment information for the fee to Xavier University, Attention: Matty Toomb, 3800 Victory Pkwy., Cincinnati, OH 45207. An email will be sent confirming your registration. Attendees are responsible for their own accommodations. The conference headquarter hotel is the Downtown Cincinnati Hilton Netherlands Plaza, 35 West 5th Street, Cincinnati, OH 45202, 513-421- 9100. To make reservations online, please visit the ``Venue & Logistics'' link at https://www.XavierPharmaLink.com. The hotel is expected to sellout during this timeframe, so early reservation in the conference room-block is encouraged. If you need special accommodations due to a disability, please contact Marla Phillips (see Contact Persons) at least 7 days in advance of the conference. SUPPLEMENTARY INFORMATION: The public conference helps fulfill the Department of Health and Human Services and FDA's important mission to protect the public health. The conference will engage those involved in FDA-regulated global supply chain quality and management through the following topics:The Impact of ``The CDER Challenge'' to Industry FDA and the Medicines and Healthcare Products Regulatory Agency (MHRA) Investigator Insights Operationalizing Effective Contract Partnerships Comparing Metrics with Other Companies--is There a Way? Why is it Vital? Complex Supply Chain Development The FDA Safety and Innovation Act (FDASIA): The New Frontier Why Your Incoming Supply is Not Reliable--Shifting Paradigms Innovation Versus Safety--The Impact of the Center for Drug Evaluation and Research's Restructure MHRA Perspective on Global Supply Chain Challenges How Did They Do That? Learn from Other Industries! The conference includes: Networking by topic Case studies Small group discussions Action plans Keynote dinner at the Cincinnati Reds Baseball Stadium with the Chief Executive Officer of Patheon, James Mullen The most pressing challenges of the global pharmaceutical industry require solutions which are inspired by collaboration to ensure the ongoing health and safety of patients. These challenges include designing products with the patient in mind, building quality into the product from the onset, selecting the right suppliers, and considering total product life-cycle systems. Meeting these challenges requires vigilance, innovation, supply chain strategy, relationship management, proactive change management, and a commitment to doing the job right the first time. FDA has made education of the drug and device manufacturing community a high priority to help ensure the quality of FDA-regulated drugs and devices. The conference helps to achieve objectives set forth in section 406 of the Food and Drug Administration Modernization Act of 1997 (21 U.S.C. 393), which includes working closely with stakeholders and maximizing the availability and clarity of information to stakeholders and the public. The conference also is consistent with the Small Business Regulatory Enforcement Fairness Act of 1996 (Pub. L. 104-121) by providing outreach activities by Government Agencies to small businesses. Dated: February 12, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014-03454 Filed 2-14-14; 8:45 am] BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
